Contributors
-
3 Steps Drug Manufacturers Can Take To Mitigate Revenue Loss From Drug Rebate Noncompliance
Drug manufacturers can’t wave a magic wand and streamline government drug discount programs. Nonetheless, there are actions manufacturers can take to mitigate the impact of noncompliant rebates
-
Prescribing Change for the Impact Pharmacists Can Make in Healthcare
Even as value-based care finds its footing and expands further, team-based approaches to care delivery incorporating pharmacists as crucial connections are already bearing results—helping provider organizations achieve 5-star CMS ratings for medication adherence, driving down costs, and driving up the quality of life for patients.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
The New Normal in Healthcare Marketing
AI can index company narratives relative to strategy, opportunities, and threats, and create benchmarks to watch over time related to sentiment, intensity, and impressions. Ultimately these can be tied back to ROI and stakeholder value that move past typical marketing performance metrics or traditional brand metrics.
-
How My Brother’s Death Changed The Way I Think About Mental Health Care
As clinical psychologists, we talk about therapy as the gold standard. I’m not saying it isn’t, but if only a minority of people are getting it, we need to broaden our perspective.
-
Hospital Downtime Planning: The Right Strategy & Technology to Ensure Uninterrupted Patient Care
It’s never a question of whether a hospital will experience downtime — it’s a matter of when. Adopting the right downtime technology means hospitals can cut costs, reduce stress on staff and mitigate risk of cyberattack by automatically encrypting data to HIPAA standards.
-
MedCity Influencers, BioPharma
Clinical Trials Have A Data Problem. Here’s How The Industry Can Solve It.
To maximize the digital clinical trial opportunity, it is imperative to establish a solid foundation of data collection and management best practices and capitalize on the advancements in data management technologies.
-
MedCity Influencers, Devices & Diagnostics
Medical Devices Are Evolving Toward Specialized Solutions
Medical devices have existed in some form for centuries, resulting in thousands of innovative implementations […]
-
The Urgent Care Crisis of Low Reimbursement: A Looming Threat to Accessible Healthcare
I invite insurance companies to engage in meaningful dialogue with urgent care providers to understand the challenges they face and explore fair reimbursement models that reflect the value they bring to patients.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
MedCity Influencers, Devices & Diagnostics
To Optimize Health Outcomes, Home Medical Devices Must Operate Within Disease Management Programs
Rich multimedia content, chatbots and human interaction all play important roles in helping new health technologies become part of a patient’s lifestyle.
-
MedCity Influencers, BioPharma
The New Opportunity to Help Rare Disease Patients
In 2020, 46.9% of all novel drugs approved by the FDA were for rare diseases, as compared to 23.5% in 2012. Investment is expected to continue trending upward, with estimates suggesting that global spending on rare disease therapies will reach $260 billion by the end of 2025.
-
MedCity Influencers, BioPharma
Closing the Oral Drug Gap
Patients are driving the push away from needles, and there are a number of novel approaches attempting to solve the difficult task of transforming biologics into orally administered treatments.
-
Prioritize Prevention in State Opioid Settlement Plans
While communities should tailor their opioid settlement spending strategies to their local needs, we should embrace basic, population-focused prevention strategies. Prevention efforts can turn the tide of addiction for decades to come. And they are where we’ll get the biggest bang for our buck.
-
U.S. Healthcare Pandemic Recovery Requires Focused Support of Independent Primary Care
Independent primary care practices are at risk of extinction. The U.S. must re-dedicate itself to the preservation of independent primary care over the long run and must undergo a radical reorientation of the health system toward primary care.
-
Consumer Choice Is the Key to Solving Our Massive Prescription Drugs Non-Adherence Problem
What we need to overcome adherence challenges is a digitally enabled marketplace of options that can be personalized to the patient and the context of their specific condition, pharmacy preference and ability to pay.
-
How a ‘Costco Model’ for Health Care Supply Chain Presents a Best Bet for Value
By reimagining health care supply chain as a centralized, high-value distribution and product selection and procurement model, hospitals and health systems can more effectively reach their goals for expense reduction while driving substantial improvements for patients and team members alike.
-
Covid is Still With Us. What Does That Mean for Your Brain?
We may not fully understand the link between Covid-19 and Alzheimer’s, but we already have the scientific research and tools to address people’s fears, support their cognitive health journey, and reverse the increase of Alzheimer’s.